- Division of Basic and Integrative Biological Sciences – DBIB
- Oncology 1 Basic Translational – OBT
- Study Section:
- Tumor Cell Biology – TCB
Dr. Morrow is the Scientific Review Officer for the Tumor Cell Biology Study Section.
He received a Ph.D. in biochemistry from Saint Louis University and an M.D. from University of Missouri-Columbia. He completed training in pediatrics at Duke University and in pediatric hematology/oncology at the National Cancer Institute. Prior to joining CSR, Dr. Morrow was professor of biochemistry at Wake Forest University School of Medicine, where his research explored the roles of ABC efflux transporters and phase II metabolizing enzymes in cancer drug resistance, xenobiotic detoxification, chemoprevention, and electrophilic lipid signaling.